GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
Antibodies against glutamic acid decarboxylase (GAD), originally linked to stiff person syndrome (SPS), now denote the “ GAD antibody-spectrum disorders ” ( GAD-SD ) that also include autoimmune epilepsy, limbic encephalitis, cerebellar ataxia and nystagmus with overlapping symptomatology highlighti...
Main Authors: | Popianna Tsiortou, Harry Alexopoulos, Marinos C. Dalakas |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-03-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864211003486 |
Similar Items
-
Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
by: Marinos C. Dalakas
Published: (2018-01-01) -
Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
by: Marinos C. Dalakas, et al.
Published: (2021-02-01) -
Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
by: Goran Rakocevic, et al.
Published: (2019-01-01) -
Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss.
by: Thashi Chang, et al.
Published: (2013-01-01) -
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome
by: Dalakas, M.C, et al.
Published: (2022)